N-(2-Chlorophenyl)-3-(4-phenyl-5-sulfanyl-4H-1,2,4-triazol-3-yl)benzene-1-sulfonamide

Catalog No.: 
ACXLRV174
CAS No.: 
748776-60-5
Molecular Formula: 
C20H15ClN4O2S2
Molecular Weight: 
442.95
N-(2-Chlorophenyl)-3-(4-phenyl-5-sulfanyl-4H-1,2,4-triazol-3-yl)benzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$179.00InquiryInquiry
5g95%$495.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Chlorophenyl)-3-(4-phenyl-5-sulfanyl-4H-1,2,4-triazol-3-yl)benzene-1-sulfonamide
IUPAC NameN-(2-chlorophenyl)-3-(5-mercapto-4-phenyl-4H-1,2,4-triazol-3-yl)benzenesulfonamide
MDL No.MFCD03653068
Molecular FormulaC20H15ClN4O2S2
Molecular Weight442.95
SMILESO=S(C1=CC=CC(C2=NN=C(S)N2C3=CC=CC=C3)=C1)(NC4=CC=CC=C4Cl)=O
InChI KeyZTBKVJKTNYEBCF-UHFFFAOYSA-N
SynonymBenzenesulfonamide, N-(2-chlorophenyl)-3-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-
CAS No.748776-60-5

Synthetic Route by SureRoute

1. ACXLRV174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACXLRV174 route product structure diagram
    ACXLRV174748776-60-5
Inquiry

2. ACXLRV174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLRV174 route product structure diagram
    ACXLRV174748776-60-5
Inquiry

3. ACXLRV174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLRV174 route product structure diagram
    ACXLRV174748776-60-5
Inquiry

Comments (0)